Clincosm LogoSign in Get a demo

primary breast cancer

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Breast Cancer Trial (SPECT)

Not yet recruiting
  • Primary Breast Cancer
  • (no location specified)
Jun 19, 2023

Primary Breast Cancer Trial in Aachen (Application and measurement of tumor vascularization using diagnostic contrast enhanced

Recruiting
  • Primary Breast Cancer
  • Application and measurement of tumor vascularization using diagnostic contrast enhanced ultrasound (CEUS)
  • Aachen, NRW, Germany
    Department of Gynecology and Obstetrics Universitätsklinikum Aac
Jun 29, 2022

Breast Cancer Proteomics and Molecular Heterogeneity

Recruiting
  • Primary Breast Cancer
  • Recurrent/Metastatic Breast Cancer
    • Dublin 4, Ireland
    • +1 more
    Jan 14, 2022

    Primary Breast Cancer Trial in Beijing (paclitaxel/anthracycline)

    Active, not recruiting
    • Primary Breast Cancer
    • Beijing, China
    • +6 more
    Nov 26, 2021

    Primary Breast Cancer Trial in Tomsk (SPECT)

    Completed
    • Primary Breast Cancer
    • Tomsk, Russian Federation
      TomskNRMC
    Oct 4, 2021

    Placement in Primary Lesions of Breast Cancer Patients Receiving

    Recruiting
    • Primary Breast Cancer
    • Tumark® Vision clip
    • Essen, Germany
      Interdisciplinary Breast Unit, Kliniken Essen-Mitte
    Aug 17, 2021

    Primary Breast Cancer Trial in Beijing (Vinorelbine)

    Recruiting
    • Primary Breast Cancer
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Oct 26, 2020

    Primary Breast Cancer Trial in Shanghai (Docetaxel Cyclophosphamide, Cyclophosphamide Fluorouracil Epirubicin Docetaxel,

    Completed
    • Primary Breast Cancer
    • Docetaxel Cyclophosphamide
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    May 17, 2020

    Primary Breast Cancer Trial (Paclitaxel, Docetaxel, Cyclophosphamide)

    Completed
    • Primary Breast Cancer
    • (no location specified)
    Feb 23, 2020

    Primary Breast Cancer Trial in Portland (Enhanced ICCS with KPNW web resources and the Comprehensive Health Enhancement Support

    Completed
    • Primary Breast Cancer
    • Enhanced ICCS with KPNW web resources and the Comprehensive Health Enhancement Support System (CHESS.)
    • Portland, Oregon
      Kaiser Permanente Northwest
    Nov 14, 2019

    Primary Breast Cancer, Her2 Non-overexpressing Trial in Moenchengladbach (Epirubicin, Cyclophosphamide, Docetaxel)

    Completed
    • Primary Breast Cancer
    • Her2 Non-overexpressing
    • Moenchengladbach, Germany
      Bethesda Krankenhaus
    Aug 12, 2019

    Primary Breast Cancer Trial in Düsseldorf (Cabacitaxel, Paclitaxel)

    Completed
    • Primary Breast Cancer
    • Düsseldorf, Germany
      Luisenkrankenhaus
    Jul 31, 2017

    Primary Breast Cancer Trial in Halle, Magdeburg, Weissenfels (Epirubicin, Carboplatin, Docetaxel)

    Completed
    • Primary Breast Cancer
    • Epirubicin, Carboplatin, Docetaxel
    • Halle, Sachsen-Anhalt, Germany
    • +2 more
    Jan 14, 2010

    Primary Breast Cancer Trial in Germany (Zoledronic acid + Calcium/Vitamin D)

    Terminated
    • Primary Breast Cancer
    • Zoledronic acid + Calcium/Vitamin D
    • Bielefeld, Germany
    • +3 more
    Dec 21, 2009

    Primary Breast Cancer Trial in Neu-Isenburg (Adriamycin (Doxorubicin), Docetaxel, Tamoxifen, Adriamycin (Doxorubicin),

    Completed
    • Primary Breast Cancer
    • Adriamycin (Doxorubicin), Docetaxel, Tamoxifen
    • Adriamycin (Doxorubicin), Docetaxel, Tamoxifen, Cyclophosphamid
    • Neu-Isenburg, Hessen, Germany
      German Breast Group
    Nov 18, 2008